Arg1:Logical subject, patient, thing rising
Arg2:EXT, amount risen
Arg3:start point
Arg4:end point
ArgM-LOC:medium
with EXT and end point (-) | |
---|---|
| |
Arg1: | The Nasdaq 100 index |
REL: | gained |
Arg2-EXT: | 1.39 |
Arg4-to: | 446.62 |
Argm-LOC: | on heavy volume |
all args! (-) | |
---|---|
| |
Arg1: | Revenue |
REL: | gained |
Arg2-EXT: | 13% |
Arg4-to: | to $77million |
Arg3-from: | from $68.5 million |
Let's use EXT for numericals only, otherwise Arg2-MNR:
arg2 as manner (-) | |
---|---|
| |
Arg1: | Bond prices and the dollar both |
REL: | gained |
Arg2-MNR: | modestly |
Arg0:agent, entity acquiring something
Arg1:thing acquired
Arg2:source, gained from
Arg3:benefactive, gained for
just transitive (-) | |
---|---|
| |
Arg0: | The company |
ArgM-MOD: | could |
REL: | gain |
Arg1: | millions of dollars |
ArgM-ADV: | if the deal goes though |
another transitive (-) | |
---|---|
| |
Arg0: | Both contracts |
REL: | have gained |
Arg1: | a following |
ArgM-TMP: | since the 1987 global market crash |
with benefactive (-) | |
---|---|
| |
Arg0: | *trace* |
REL: | gain |
Arg1: | bank loans |
Arg3-for: | the labor management group. |
with source (-) | |
---|---|
| |
Arg0: | Both companies |
REL: | would gain |
Arg1: | technological knowledge |
Arg2-through: | the sale of GenProbe |